Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/1275
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Complementary and alternative medicine use in breast cancer patients in Europe
Authors: Molassiotis, Alexander
Scott, Julia
Kearney, Nora
Pud, Dorit
Magri, Miriam
Selvekerova, Sarka
Bruyns, Ingrid
Fernandez-Ortega, Paz
Panteli, Vassiliki
Margulies, Anita
Gudmundsdottir, Gudbjorg
Milovics, Ljiljana
Ozden, Gulten
Platin, Nurgun
Patiraki, Elisabeth
Contact Email: nora.kearney@stir.ac.uk
Keywords: Complementary medicine
Alternative medicine
complementary therapies
Breast cancer
Europe
Issue Date: Mar-2006
Publisher: Springer
Citation: Molassiotis A, Scott J, Kearney N, Pud D, Magri M, Selvekerova S, Bruyns I, Fernandez-Ortega P, Panteli V, Margulies A, Gudmundsdottir G, Milovics L, Ozden G, Platin N & Patiraki E (2006) Complementary and alternative medicine use in breast cancer patients in Europe, Supportive Care in Cancer, 14 (3), pp. 260-267.
Abstract: Complementary and alternative medicine (CAM) has gained popularity among cancer patients in the past years. For this study, CAM includes any group of health care systems, practices or products that are not considered to be part of conventional medicine at present (National Center for Complementary and Alternative Medicine). The present study assessed patterns of CAM use in breast cancer patients in Europe. The study used a descriptive cross-sectional design, and data were collected through a 27-item questionnaire. The sample, which was part of a larger study, consisted of 282 breast cancer patients from 11 countries in Europe. Among participants, 44.7% used CAM since their diagnosis of cancer. The most common therapies used included herbal medicine (46.4%) and medicinal teas, relaxation techniques, spiritual therapies, homeopathy and vitamins/minerals. Younger patients with higher education and who had received combination treatments for their cancer in the past were more likely to use CAM. High levels of satisfaction were reported, with only 6.5% of the women reporting no benefits from the CAM used. Main sources of information about CAM were mostly friends/family and the media. Findings suggested that a high proportion of breast cancer patients used CAM, which may have implications for the clinical management of these patients.
Type: Journal Article
URI: http://hdl.handle.net/1893/1275
DOI Link: http://dx.doi.org/10.1007/s00520-005-0883-7
Rights: The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.
Affiliation: University of Manchester
HS UG Regulated - Stirling
Cancer Care Research Centre
University of Haifa
University of Milan
Masaryk Memorial Cancer Institute
Belgian Society of Oncology Nursing
Institut CatalĂ  Oncologia ICO
Greek Oncology Nursing Society
University Hospital Zurich
Department of Oncology, Landspitali
Institute for Oncology and Radiology, Serbia
Gazi University Hospital
Koc University
Greek Oncology Nursing Society

Files in This Item:
File Description SizeFormat 
Molassiotis - Complementary and alternative medicine use in breast cancer patients in Europe.pdf109.19 kBAdobe PDFUnder Embargo until 31/12/2999     Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependant on the depositor still being contactable at their original email address.

This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.